Biocompatibility parameters in in-vitro simulated automated versus continuous ambulatory peritoneal dialysis

Clinical Nephrology

Volumn 64, Issue 3, 2005, Pages 214-220

  Fusshoeller, Andreas ^a,b   Baehr, J ^a   Tiemann, J B ^a   Grabensee, B ^a   Plum, J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE   (Germany)

Author keywords

Automated peritoneal dialysis; Biocompatibility; CA125; Cell culture model; Peritoneal host defense; TGF 1

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CA 125 ANTIGEN; INTERLEUKIN 6; PERITONEAL DIALYSIS FLUID; TRANSFORMING GROWTH FACTOR BETA1;

ANALYTICAL PARAMETERS; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DIALYSATE; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; MESOTHELIUM CELL; PROCESS MODEL; RETROPERITONEAL FIBROSIS; STATISTICAL ANALYSIS;

EID: 24644443250     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp64214     Document Type: Article

References (28)

1. Breborowicz A, Martis L, Oreopoulos DG 1995 Changes in biocompatibility of dialysis fluid during its dwell in the peritoneal cavity. Perit Dial Int 15: 152-157
2. Bro S, Bjorner JB, Tofte-Jensen P, Klem S, Almtoft B, Danielsen H, Meincke M, Friedberg M, Feldt-Rasmussen B 1999 A prospective, randomised multicenter study comparing APD and CAPD treatment. Perit Dial Int 19: 526-533
3. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, Divino Filho JC, Vonesh E, van Bree M, EAPOS Group 2003 Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 14: 2948-2957
4. Davies SJ, Bryan J, Phillips L, Russell GI 1996 Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 11: 498-506
5. Diaz-Buxo JA 2000 The present and the future of APD. Clin Nephrol 53: 411-416
6. de Fijter CW, Verbrugh HA, Oe LP, Peters ED, van der Meulen J, Donker AJ, Verhoef J 1992 Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 42: 947-950
7. Douvdevanni A, Rapoport J, Konforti A, Zlotnik M, Chaimovitz C 1993 The effect of peritoneal dialysis fluid on the release of IL-1 beta and TNF alpha by macrophages/monocytes. Perit Dial Int 13: 112-117
8. Fusshoeller A, zur Nieden S, Grabensee B, Plum J 2002 Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence. J Am Soc Nephrol 13: 1055-1060
9. Fusshoeller A, Grabensee B, Plum J 2003 Effluent CA125 concentration in chronic peritoneal dialysis patients: influence of PD duration, peritoneal transport and PD regimen. Kidney Blood Press Res 26: 118-122
10. Fusshoeller A, Plail M, Grabensee B, Plum J 2004 Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD - a prospective, randomized study. Nephrol Dial Transplant 19: 2101-2106
11. Fusshoeller A, Baehr J, Grabensee B, Plum J 2005 Biocompatibility of a bicarbonate/lactate buffered PD fluid tested with a double chamber cell culture system. Perit Dial Int (in press)
12. Ha H, Yu MR, Lee HB 2001 High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 59: 463-470
13. Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, Krediet RT 1997 Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 51: 888-893
14. Jorres A, Bender TO, Finn A, Witowski J, Frohlich S, Gahl GM, Frei U, Keck H, Passlick-Deeyen J 1998 Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int 54: 2184-2193
15. Lee JH, Reddy DK, Saran R, Moore HL, Twardowski ZJ, Nolph KD, Khanna R 2000 Advanced glycosylation end products in diabetic rats on peritoneal dialysis using various solutions. Perit Dial Int 20: 643-651
16. Mateijsen MA, van der Wil AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, Krediet RT 1999 Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19: 517-525
17. Monquil MC, Imholz AL, Struyk DG, Krediet RT 1995 Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD? Perit Dial Int 15: 42-48
18. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, Hayakawa H, Osaka N, Yamamoto H, Ogawa A, Kubo H, Shigematsu T, Sakai O, Horiuchi S 1997 Immunohistochemical detection of advanced glycosylation end products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 51: 182-186
19. Plum J, Razeghi P, Lordnejad RM, Perniok A, Fleisch M, Fusshoeller A, Schneider M, Grabensee B 2001 Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer effects on human mesothelial cells. Am J Kidney Dis 38: 867-875
20. Plum J, Hermann S, Fusshoeller A, Schoenicke G, Donner A, Rohrborn A, Grabensee R 2001 Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int 78 (Suppl): S42-S47
21. Rippe B, Simonsen O, Heimburger O, Christensson A, Haraldsson B, Stelin G, Weiss L, Nielsen FD, Bro S, Friedberg M, Wieslander A 2001 Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 59: 348-357
22. Shostak A, Pivnik K, Gotloib L 1996 Daily short exposure of cultured mesothelial cells to lactated, high-glucose, low-pH peritoneal dialysis fluid induces a low-profile regenerative steady state. Nephrol Dial Transplant 11: 608-613
23. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD 1990 Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 37: 1563-1570
24. Topley N, Alobaidi HM, Davies M, Coles GA, Williams JD, Lloyd D 1988 The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 34: 404-411
25. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jorres A 2001 Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 12: 2434-2441
26. Witowski J, Jorres A, Coles GA, Williams JD, Topley N 1996 Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL-6 mRNA. Kidney Int 50: 1212-1223
27. Wrenger E, Baumann C, Behrend M, Zamore E, Schindler R, Brunkhorst R 1998 Peritoneal mononuclear cell differentiation and cytokine production in intermittent and continuous automated peritoneal dialysis. Am J Kidney Dis 31: 234-241
28. Yang AH, Chen JY, Lin YP, Huang TP, Wu CW 1997 Peritoneal dialysis solution induces apoptosis of mesothelial cells. Kidney Int 51: 1280-1288